23andMe has been quietly exploring a possible sale of its telehealth business, Lemonaid Rebecca Torrence 17 jan 2025
Datavant is on the M&A hunt as the $7B health data company bulks up before a potential IPO Rebecca Torrence 07 jan 2025
Here’s what Big Pharma could buy in 2025, from obesity drugs to precision cancer treatments, according to a top M&A banker Rebecca Torrence 03 jan 2025
VC’s healthcare predictions for 2025: more M&A, fierce competition in AI, and a health insurance shake-up under Trump Rebecca Torrence 23 dec 2024
Many digital health startups are quietly raising down rounds and closing up shop. Here’s why. Rebecca Torrence 26 nov 2024
Forward’s leaders are already recruiting for a new startup, just a week after the healthcare company shut down Rob Price, Rebecca Torrence 22 nov 2024
How RFK Jr’s war on obesity in the age of Ozempic could shake up the booming weight-loss industry Rebecca Torrence, Hilary Brueck 19 nov 2024
$3 billion startup Sword Health cuts some physical therapists as it ramps up AI to treat more patients Rebecca Torrence 11 nov 2024
Silicon Valley is on edge as Trump’s immigration policy sparks fears of a high-tech talent shortage Melia Russell, Geoff Weiss, Rebecca Torrence, Helen Li 10 nov 2024
